Prepared by
Juan R. Rodríguez, MD
, a second-year Resident, and
Anil Malik, MD
, a third-year Resident, from the Department of Radiology at
Louisiana State University Health Science Center, Shreveport,
LA.
CASE SUMMARY
The patient is a 53-year-old white man with a 2-year history of
intermittent right flank pain, microhematuria, discomfort in lower
extremities, and constipation. He also suffers from hypertension
and noninsulin-dependent diabetes mellitus. The patient is obese
with no abnormal findings on physical examination. Imaging studies
performed during follow-up included intravenous pyelogram (IVP)
(Figures 1, 2, and 3), barium enema (BE) (Figure 4), computed
tomography (CT) (Figure 5), sonographic evaluation of lower
extremity venous systems, and cystoscopy. Direct visualization of
the bladder lumen by cystoscopy was normal. Laboratory values were:
BUN 12, and creatinine 0.8.
DIAGNOSIS
Pelvic lipomatosis
IMAGING FINDINGS
On plain abdominal X-rays, increased radiolucency of the
perivesical area is a sign of the presence of pelvic lipomatosis
(PL) and may be the first imaging abnormality noticed (Figure 1).
Images obtained on IVP show the abnormal shape and position of the
bladder with the appearance of an inverted teardrop caused by
extrinsic compression. The ureters are dilated, tortuous, and
displaced laterally (Figures 2 and 3). The barium enema examination
demonstrated elongation and symmetrical extrinsic compression of
the rectum and cephalad displacement of the sigmoid colon. The
appearance of the rectosigmoid in this condition has been named
tower rectum (Figure 4). The abdominal CT scan reveals that the
bladder and rectosigmoid are surrounded and displaced by fat tissue
(attenuation coefficient: 40 to 100 Hounsfield units [HU])
(Figure 5).
DISCUSSION
Pelvic lipomatosis is a disease of unknown cause, characterized
by overgrowth of mature, nonmalignant fat cells in the pelvic
region, especially in perivesical and perirectal spaces. It is a
rare disease; the incidence of PL in the United States was
estimated as 0.6 to 1.7 per 100,000 hospital admissions between
1967 and 1975.
1
It may be more common than is indicated by the number of reports
published, however. Pelvic lipomatosis is more frequent in males
and African Americans.
2
In 1959, Engels
3
first described 5 patients with bizarre deformities of the sigmoid
colon and bladder, which were discovered on barium enema and
cystography. The clinical presentation of PL is related to the
compressive phenomenon on the urinary system (increased frequency,
dysuria, nocturia, and hematuria), lower intestinal tract
(constipation, tenesmus, rectal bleeding, and ribbon-like stools
with mucus), and vascular system (edema of lower extremities).
Several authors have developed theories to explain its cause. It
was initially suggested that PL results from chronic lower
urinary-tract infection.
3,4
When such infection is present in these patients, the distribution
of the fat in the pelvis may be the result rather than its cause.
5
Pelvic lipomatosis has been linked to obesity
6
; however, weight loss as therapy has not shown an improvement of
the disease. Other theories connect PL with an endocrine
dysfunction, but in only a small amount of cases was an endocrine
abnormality found, such as diabetes mellitus or Cushing's disease.
6,7
The differential diagnosis of the bladder deformity typical of
PL includes several other conditions. Such deformity may result
from hypertrophy of the iliopsoas muscles,
8
retroperitoneal fibrosis,
9
large pelvic abscess, or a large hematoma, usually due to trauma or
anticoagulation therapy.
10
Additionally, collateral venous circulation from vena cava
obstruction,
10
large iliac artery aneurysms,
11
adenopathy from lymphoma, and prostatic carcinoma
10,11
may cause a tear-drop shaped bladder and rectal extrinsic
compression.
A conservative approach, the use of symptomatic treatment and
follow-up, is indicated in cases with minor symptoms and with no
repercussion over the renal function. In a review of this topic,
Heyns
2
describes various therapeutic options currently in use for
treatment of PL. Conservative alternatives, such as long-term
antimicrobial treatment, steroids, or dietary control, are
ineffective.
12
Some authors have tried radiotherapy without success.
13
Upper-tract urinary diversion is needed for patients with severe
symptoms and/or evidence of urinary obstruction with deterioration
of the renal function. Several techniques are described in the
literature.
9,11
Halachmi et al
14
reported the case of a 60-year-old man with PL that caused severe
urinary tract obstruction, which was treated successfully with the
use of an ultrasonic-assisted lipectomy device and reimplantation
of the ureters at the bladder dome.
Although the condition does not show progression in most cases,
it is impossible to predict which patients will experience
deteriorating renal function. There is no evidence to support the
suggestion of Carpenter,
12
who stated that the prognosis of PL is worse in young men than in
older patients. Follow-up of patients with PL is important to
detect those in whom PL evolves and causes renal function
deterioration. Urinary diversion may eventually be required to
prevent obstructive uropathy from causing end stage renal
disease.
ACKNOWLEDGMENTS
The authors thank Dr. Horacio B. D'agostino for his constant
support and efforts as Chairman of our department; and would also
like to thank Mrs. Evelyn Morris, radiologic technician, for her
assistance.